PLCB1 and central nervous system cancer: In this study, we retrieved data and performed analyses to determine (1) if PLCβ1 is a candidate signature gene for the PN subtype glioma, (2) the potential correlation between its expression and glioma’s pathological grades, and (3) its prognostic value in glioma patients.